• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床痴呆评定量表的项目反应理论分析。

Item response theory analysis of the Clinical Dementia Rating.

机构信息

Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.

Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri, USA.

出版信息

Alzheimers Dement. 2021 Mar;17(3):534-542. doi: 10.1002/alz.12210. Epub 2020 Nov 20.

DOI:10.1002/alz.12210
PMID:33215873
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8016711/
Abstract

INTRODUCTION

The Clinical Dementia Rating (CDR) is widely used in Alzheimer's disease research studies and has well established reliability and validity. To facilitate the development of an online, electronic CDR (eCDR) for more efficient clinical applications, this study aims to produce a shortened version of the CDR, and to develop the statistical model for automatic scoring.

METHODS

Item response theory (IRT) was used for item evaluation and model development. An automatic scoring algorithm was validated using existing CDR global and domain box scores as the reference standard.

RESULTS

Most CDR items discriminate well at mild and very mild levels of cognitive impairment. The bi-factor IRT model fits best and the shortened CDR still demonstrates very high classification accuracy (81%∼92%).

DISCUSSION

The shortened version of the CDR and the automatic scoring algorithm has established a good foundation for developing an eCDR and will ultimately improve the efficiency of cognitive assessment.

摘要

简介

临床痴呆评定量表(CDR)在阿尔茨海默病研究中被广泛应用,其具有可靠的信度和效度。为了促进在线电子 CDR(eCDR)的发展,以实现更高效的临床应用,本研究旨在制定 CDR 的简化版本,并开发自动评分的统计模型。

方法

本研究采用项目反应理论(IRT)进行项目评估和模型开发。利用现有的 CDR 全球和领域评分箱作为参考标准,对自动评分算法进行验证。

结果

在轻度和极轻度认知障碍水平上,大多数 CDR 项目的区分度良好。双因素 IRT 模型拟合度最佳,简化的 CDR 仍具有非常高的分类准确性(81%∼92%)。

讨论

CDR 的简化版本和自动评分算法为开发 eCDR 奠定了良好的基础,最终将提高认知评估的效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/e2e3dd2c58bd/nihms-1667956-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/77a4e19473c2/nihms-1667956-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/b3d0f0f97638/nihms-1667956-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/e2e3dd2c58bd/nihms-1667956-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/77a4e19473c2/nihms-1667956-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/b3d0f0f97638/nihms-1667956-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a40/8016711/e2e3dd2c58bd/nihms-1667956-f0003.jpg

相似文献

1
Item response theory analysis of the Clinical Dementia Rating.临床痴呆评定量表的项目反应理论分析。
Alzheimers Dement. 2021 Mar;17(3):534-542. doi: 10.1002/alz.12210. Epub 2020 Nov 20.
2
Detecting Treatment Group Differences in Alzheimer's Disease Clinical Trials: A Comparison of Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog) and the Clinical Dementia Rating - Sum of Boxes (CDR-SB).阿尔茨海默病临床试验中治疗组差异的检测:阿尔茨海默病评估量表-认知分量表(ADAS-Cog)与临床痴呆评定量表-总盒分(CDR-SB)的比较。
J Prev Alzheimers Dis. 2018;5(1):15-20. doi: 10.14283/jpad.2018.2.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
5
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍(MCI)患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表(MMSE)。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
6
Extension and external validation of mapping between the Mini-Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer's disease.阿尔茨海默病患者简易精神状态检查表与临床痴呆评定量表之间映射关系的扩展及外部验证
Alzheimers Dement. 2025 Jun;21(6):e70163. doi: 10.1002/alz.70163.
7
Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a primary care setting.在初级保健机构中用于诊断阿尔茨海默病性痴呆及其他痴呆的简易认知评估工具。
Cochrane Database Syst Rev. 2018 Feb 22;2(2):CD011415. doi: 10.1002/14651858.CD011415.pub2.
8
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
9
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
10
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.

引用本文的文献

1
Peruvian validation and standardization of the TabCAT-brain health assessment.TabCAT脑健康评估的秘鲁验证与标准化
Front Public Health. 2025 Aug 29;13:1600131. doi: 10.3389/fpubh.2025.1600131. eCollection 2025.
2
Fast Declining Prediction in Alzheimer's Disease from Early Clinical Assessment.基于早期临床评估的阿尔茨海默病快速衰退预测
Curr Neuropharmacol. 2025;23(5):602-611. doi: 10.2174/011570159X332930240925095423.
3
Transcutaneous Electrical Acupoint Stimulation for Elders with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot and Feasibility Trial.

本文引用的文献

1
Reporting Valid and Reliable Overall Scores and Domain Scores Using Bi-Factor Model.使用双因素模型报告有效且可靠的总体得分和领域得分。
Appl Psychol Meas. 2019 Oct;43(7):562-576. doi: 10.1177/0146621618813093. Epub 2018 Dec 10.
2
Application of a multidimensional computerized adaptive test for a Clinical Dementia Rating Scale through computer-aided techniques.通过计算机辅助技术将多维计算机自适应测试应用于临床痴呆评定量表。
Ann Gen Psychiatry. 2019 May 17;18:5. doi: 10.1186/s12991-019-0228-4. eCollection 2019.
3
Youden index and Associated Cut-points for Three Ordinal Diagnostic Groups.
经皮穴位电刺激治疗遗忘型轻度认知障碍老年人:一项随机对照试验和可行性研究。
Healthcare (Basel). 2024 Sep 28;12(19):1945. doi: 10.3390/healthcare12191945.
4
The Effect of Acupuncture on Brain Iron Deposition and Body Iron Metabolism in Vascular Cognitive Impairment: Protocol for a Randomized Controlled Trial.针刺对血管性认知障碍患者脑铁沉积和体铁代谢的影响:一项随机对照试验方案。
JMIR Res Protoc. 2024 Jun 17;13:e56484. doi: 10.2196/56484.
5
Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling.通过纵向项目反应理论建模评估替拉沃单抗在早期阿尔茨海默病中的疗效。
Alzheimers Dement (N Y). 2024 Jun 4;10(2):e12471. doi: 10.1002/trc2.12471. eCollection 2024 Apr-Jun.
6
Monocytes release cystatin F dimer to associate with Aβ and aggravate amyloid pathology and cognitive deficits in Alzheimer's disease.单核细胞释放半胱氨酸蛋白酶抑制剂 F 二聚体与 Aβ 结合,加重阿尔茨海默病的淀粉样病理和认知缺陷。
J Neuroinflammation. 2024 May 10;21(1):125. doi: 10.1186/s12974-024-03119-2.
7
Hearing intervention for decreasing risk of developing dementia in elders with mild cognitive impairment: study protocol of a multicenter randomized controlled trial for Chinese Hearing Solution for Improvement of Cognition in Elders (CHOICE).针对轻度认知障碍老年人降低痴呆风险的听力干预:多中心随机对照试验研究方案——中国老年人听力改善认知方案(CHOICE)。
Trials. 2023 Nov 28;24(1):767. doi: 10.1186/s13063-023-07813-z.
8
Brain-derived neurotrophic factor gene polymorphism affects cognitive function and neurofilament light chain level in patients with subcortical ischaemic vascular dementia.脑源性神经营养因子基因多态性影响皮质下缺血性血管性痴呆患者的认知功能和神经丝轻链水平。
Front Aging Neurosci. 2023 Oct 9;15:1244191. doi: 10.3389/fnagi.2023.1244191. eCollection 2023.
9
Early Alzheimer's Disease Screening Approach Using Plasma Biomarkers.使用血浆生物标志物的早期阿尔茨海默病筛查方法
Int J Mol Sci. 2023 Sep 15;24(18):14151. doi: 10.3390/ijms241814151.
10
Evaluation of the Electronic Clinical Dementia Rating for Dementia Screening.电子临床痴呆评定量表用于痴呆筛查的评估。
JAMA Netw Open. 2023 Sep 5;6(9):e2333786. doi: 10.1001/jamanetworkopen.2023.33786.
三个有序诊断组的约登指数及相关切点
Commun Stat Simul Comput. 2013 Jan;42(6):1213-1234. doi: 10.1080/03610918.2012.661906.
4
DiagTest3Grp: An R Package for Analyzing Diagnostic Tests with Three Ordinal Groups.DiagTest3Grp:一个用于分析具有三个有序组的诊断测试的R软件包。
J Stat Softw. 2012 Oct;51(3):1-24. doi: 10.18637/jss.v051.i03. Epub 2012 Sep 22.
5
Greater precision when measuring dementia severity: establishing item parameters for the Clinical Dementia Rating Scale.更精确地测量痴呆严重程度:建立临床痴呆评定量表的项目参数。
Dement Geriatr Cogn Disord. 2012;34(2):128-34. doi: 10.1159/000341731.
6
Gaining precision on the Alzheimer's Disease Assessment Scale-cognitive: a comparison of item response theory-based scores and total scores.提高阿尔茨海默病评估量表认知部分的精度:基于项目反应理论的分数与总分的比较。
Alzheimers Dement. 2012 Jul;8(4):288-94. doi: 10.1016/j.jalz.2011.05.2409. Epub 2012 Mar 30.
7
Item response theory reveals variability of functional impairment within clinical dementia rating scale stages.项目反应理论揭示了临床痴呆评定量表各阶段功能障碍的可变性。
Dement Geriatr Cogn Disord. 2011;32(5):362-6. doi: 10.1159/000335727. Epub 2012 Feb 3.
8
Dementia staging across three different methods.痴呆症的三种不同分期方法。
Dement Geriatr Cogn Disord. 2011;31(5):328-33. doi: 10.1159/000328116. Epub 2011 May 7.
9
The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.统一数据集(UDS):来自阿尔茨海默病中心的临床和认知变量及描述性数据。
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6. doi: 10.1097/01.wad.0000213865.09806.92.
10
Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.原始版与修订版轻度认知障碍及轻度认知障碍前期的纵向病程和神经病理学结果
Neurology. 2006 Aug 8;67(3):467-73. doi: 10.1212/01.wnl.0000228231.26111.6e.